• @[email protected]
    link
    fedilink
    English
    81
    edit-2
    6 months ago

    I literally worked in a research lab working on islet cell therapies for diabetes in the US. This has actually been done many times before with cells from cadavers. It has been successful, although most the of the time the person reverts back after a few years

    The issues we were trying to solve in the lab were

    1. Finding a good place to transplant where the cells will last: Implanting in the hepatic region (liver), which is the most common place to implant, is toxic to the cells over time hence only lasting 3-5 years. The cells need a really good blood supply and the volume you’re transplanting can’t be easily transplanted in the pancreas or kidney capsules (where many successful studies were performed in mice and rats)

    2. Being able to consistently make a high volume of stem cells that are fully grown into insulin producing cells: Cadaver cells usually require 3-5 donors for 1 person and require the receiver to be on lifelong immunosuppresors due to the immune response. Depending on the kind of stem cells, the patient may still even need immunosuppresors due to the cell type you’re converting from

    All this the say - the article says nothing about where the cells where transplanted, where they came from, or whether the person has Type 1 or Type 2 diabetes. Although it is still a feat, it is likely not the first time it has been done, and we’re still a long ways off from a cure

    • HubertManne
      link
      fedilink
      136 months ago

      “The new therapy involves programming the patient’s peripheral blood mononuclear cells, transforming them into “seed cells” to recreate pancreatic islet tissue in an artificial environment.”

      I don’t see anything for the other two questions though but being patient derived would seem to fix your number 2.

      • @[email protected]
        link
        fedilink
        English
        96 months ago

        Unfortunately, that doesn’t necessarily negate the requirement for immunosuppresors or some other kind of immuno protection. If it is Type 1 diabetes, the person originally became diabetic because the immune system saw certain markers on the beta cells (insulin producing cells) as a threat. So, if you recreate the beta cells, there is still a possibility that it will happen again. You are fighting your own immune system. Someone in our lab was studying encapsulation of cells to create a protective barrier around them for this very issue

        If the person was Type 2, this might be less of a risk since type 2 can also be due to high insulin resistivity. There are a lot of other factors involved, though, it’s not straightforward

    • @[email protected]
      link
      fedilink
      English
      26 months ago

      Interesting. So if you chose the hard route (implant in the pancreas through invasive surgery) would that effectively cure you? I’m betting many people would be willing to take the risks

      • @[email protected]
        link
        fedilink
        English
        6
        edit-2
        6 months ago

        The pancreas is not really stable enough to be implanted in at all. Other organs you’re imagining like liver, stomach, heart, etc. have a solid lining that can be cut open and stitched back together. The pancreas is more like a cluster of loose cells with veins throughout and held together by a very thin, tissue paper lining. If you try to open it and insert cells, you’re not going to be able to put it back together.

        That’s why cells are usually put in the liver, which has a large vein going directly to the pancreas. Close proximity and high blood supply. Implanting in the pancreas will likely never be an option unless you can drastically reduce the volume of cells.

        Our lab was working on implanting the stem cells on a porous scaffold in the fat pad of the stomach as an alternative

  • @[email protected]
    link
    fedilink
    English
    626 months ago

    Interesting, but that headline is misleading.

    A single patient was weaned off blood sugar medication over a year and hasn’t redeveloped diabetes in almost three years.

    There’s obviously a lot more research into the cell therapy process and many more patients are going to have to undergo this therapy in controlled conditions before we can call it a new cure.

    Right now, this is an interesting medical anomaly that occurred over more than a year of treatment in which someone’s pancreatic process was restored in correlation with a new cell therapy.

    • @[email protected]OP
      link
      fedilink
      English
      46 months ago

      First human trial for a treatment strategy passed (notably, we know that placebo treatments for diabetes fail). This more than passes the bar to justify further large-scale human trials and, clinically, is a very strong indicator of success.

      What, is it not a cure until it’s available to the public?

      • @[email protected]
        link
        fedilink
        English
        166 months ago

        It justifies, in fact begs for human trials, but a single unregulated data point from a single moment is hardly a cure.

        It becomes a cure after the treatment is isolated from mitigating factors and acutely applied to the same disorder in many patients in controlled conditions with peer-reviewed and independently confirmed repeatable results over time.

      • @ReallyActuallyFrankenstein
        link
        English
        86 months ago

        Well, the phrase is, “the plural of anecdote is not statistic.” In this case, we only have a single case, so it doesn’t even escape “anecdote.” I think at that point, there isn’t yet a scientific basis to call it a “cure.”

  • @[email protected]
    link
    fedilink
    English
    236 months ago

    Until there is proof or external verification of the results, it’s just another case of Chinese propaganda.